| 
Results for januvia. Search took 0.35 seconds.
Diabetes Drug Januvia May Trigger Pancreatitis, Pancreatic Cancer
in Daily Diabetic, on April 30, 2009
... Islet Research Center found that the type 2 diabetes drug sitagliptin - sold in pill form as Januvia - could lead to a form of low-grade pancreatitis in some patients and a greater risk of ...
Takeda Filed for US Approval of Diabetes Drug Alogliptin
in Daily Diabetic, on January 4, 2008
...4 inhibitor , regulating blood glucose levels, and the class also includes Merck & Co's Januvia and Novartis AG 's Galvus ]
According to Takeda spokesman Toshiyuki Ikeuchi:
"...
Diabetes Drug Januvia Has New FDA-Approved Uses
in Daily Diabetic, on October 26, 2007
...Approved by the FDA in October 2006, the diabetes drug by Merck - Januvia (sitagliptin) - is a prescription medicine being used as part of a treatment programme (including diet and exercise) to ...
Sitagliptin-Metformin Combo, Synergistically Works Against Type 2 Diabetes
in Daily Diabetic, on September 19, 2007
...the body more responsive to insulin. On the other hand, sitagliptin or the Merck diabetes drug Januvia™ works to boost the body's ability to lower elevated blood sugar levels.
When com...
Diabetes Drug Janumet®, Under Fast Track Status in UAE
in Daily Diabetic, on April 25, 2007
The type 2 diabetes drug which combined the power of two medications, J anuvia® and metformin : Janumet® - has been given fast track status in the UAE, as reported by Gulf News .
[The UAE has the second highest rate of diabetes in the world with about one in 20 adults affected, mostly Typ...
Merck's Diabetes Drug Janumet®, Approved by the FDA
in Daily Diabetic, on April 2, 2007
...abetes by targeting all causes of the disease, is a combination of another Merck diabetes drug - Januvia® - and an older type-2 diabetes drug, metformin .
Diabetes is caused when the body doesn&#...
DPP-4 Inhibitor JANUVIA® Approved In EU for Type 2 Diabetes
in Daily Diabetic, on March 27, 2007
...rol) when its levels are elevated in the body.
One example of such kind of drug is Merck 's JANUVIA® (sitagliptin1) - the first and only prescription DPP-4 inhibitor approved by the US Food ...
DPP-4 Inhibitor by Merck: JANUVIA™, Approved by the USFDA for Type 2 Diabetes
in Straightfromthedoc, on October 20, 2006
...of class of prescription medications called dipeptidyl peptidase-4 (DPP-4) inhibitors, Merck's JANUVIA™(sitagliptin phosphate ) has recently been approved by the USFDA for the treatment o...
Merck Develops New Diabetes Treatment
in Daily Diabetic, on August 31, 2006
... Yet another diabetes drug has been let loose upon the world. Januvia, developed by Merck, is the latest treatment for diabetes. The drug, when combined with metformin , seems to reduce bloo...
Merck Steps it Up
in Daily Diabetic, on June 5, 2006
...n medical research experts are anxious to get some innovative new drugs approved, including Januvia , an oral diabetes drug. On Saturday, Merck will present key phase III data regarding Januvi...